CREXENDO financials
$5.87+0.17%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 |
|---|---|---|---|---|---|---|
| Revenue | $68.2M | $60.8M | $53.2M | $37.6M | $28.1M | $16.4M |
| Gross profit | $42.9M | $37.7M | $31.6M | $23.9M | $17.4M | $11.4M |
| Gross margin | 62.9% | 62.0% | 59.5% | 63.6% | 62.1% | 69.8% |
| Operating income | $4.7M | $1.8M | -$1.7M | -$37.4M | -$2.8M | $965.0K |
| Net income | $5.1M | $1.7M | -$362.0K | -$35.4M | -$2.4M | $7.9M |
| Net margin | 7.4% | 2.8% | −0.7% | −94.3% | −8.7% | 48.5% |
| Diluted EPS | $0.16 | $0.06 | $-0.01 | $-1.54 | $-0.12 | $0.46 |
| EBITDA | $8.0M | $5.2M | $1.9M | -$2.0M | -$1.2M | $1.2M |
| Operating cash flow | $9.3M | $6.3M | $3.5M | -$411.0K | -$1.0M | $647.0K |
| Free cash flow | $9.3M | $6.3M | $3.4M | -$700.0K | -$1.1M | — |
| Diluted shares | 31.6M | 30.0M | 25.9M | 22.9M | 20.3M | 17.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $31.4M | $18.2M | $10.3M | $5.5M | $7.5M | $17.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $116.0K | $615.0K | $1.1M | $3.3M | $2.2M | $2.0M |
| Total assets | $77.7M | $64.9M | $56.2M | $55.6M | $77.2M | $30.7M |
| Total liabilities | $13.9M | $13.5M | $11.5M | $14.2M | $11.2M | $4.9M |
| Shareholders' equity | $63.8M | $51.4M | $44.6M | $41.5M | $65.9M | $25.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology